Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Authors:
- 6 August 2025
- journal article
- practice guideline
- Published by Elsevier in Genetics in Medicine
- Vol. 27 (9) , 101505
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markersPrenatal Diagnosis, 2001
- Fetal loss in Down syndrome pregnanciesPrenatal Diagnosis, 1999
- Hyperglycosylated hcg, a potential alternative to hcg in Down syndrome screeningPrenatal Diagnosis, 1998
- hCG and the free β-subunit as screening tests for Down syndromePrenatal Diagnosis, 1998
- Erratum. Letter to the Editor: Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviationPrenatal Diagnosis, 1997
- REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTSPrenatal Diagnosis, 1996
- INSULIN‐DEPENDENT DIABETES MELLITUS AND PRENATAL SCREENING RESULTS: CURRENT EXPERIENCE FROM A REGIONAL SCREENING PROGRAMMEPrenatal Diagnosis, 1996
- MATERNAL SERUM INHIBIN-A LEVELS IN TWIN PREGNANCIES: IMPLICATIONS FOR SCREENING FOR DOWN'S SYNDROMEPrenatal Diagnosis, 1996
- Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: A proposed revised rate schedule for use in genetic and prenatal screeningAmerican Journal of Medical Genetics, 1996
- PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKERPrenatal Diagnosis, 1996